BPC-157Explore study findings
What the October 2026 compounding notice covers
2 numbered sourcesSource years 2026
Amino acids linked by peptide bonds form short chains called peptides. Some change how cells respond to signals, while others are studied to learn whether they have such activity. BPC-157 is a synthetic 15-amino-acid peptide investigated in tissue injury models. In October 2026, the U.S. Department of Health and Human Services published a notice about an interim policy on certain peptide bulk drug substances. The notice and its accompanying policy address a regulatory question about compounding. [1] [2]
The policy describes circumstances in which HHS does not intend to take enforcement action while a list of bulk drug substances is developed through rulemaking under section 503A of federal law. Its appendix identifies BPC-157 acetate and describes the conditions that apply. These include requirements for the identity and quality of the bulk substance, adverse event reporting and a single active ingredient in the compounded product. The policy applies to specified compounders under the stated conditions. [1] [2]
Drug approval asks a separate question. It involves evidence that a particular finished product is safe and effective for a defined use, along with manufacturing and labeling review. The HHS notice describes enforcement discretion, so a product covered by its conditions does not acquire an FDA-approved indication through that policy. A laboratory study of a peptide also cannot answer the same question as a controlled clinical trial of a defined product. [1] [2]
That distinction helps explain why two statements can be true at once. An agency can describe limited conditions for compounding while researchers still need clinical evidence on outcomes. A specification for a bulk ingredient establishes what substance the policy addresses. Clinical evidence is what would determine whether an intervention improves a specific health outcome. [1] [2]
Sources
Original works cited in this article. Links open the external record in a new tab.
